NCT05420948 2026-04-09A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck CancerUniversity of ChicagoPhase 2 Suspended30 enrolled
NCT05403723 2026-02-19Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCUniversity of Maryland, BaltimorePhase 1 Suspended50 enrolled